← All trials
NCT04545450
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 4, 2008
- Primary completion
- Jul 30, 2009
- Completion date
- Oct 15, 2010
- First posted
- Sep 11, 2020
- Last posted
- Sep 11, 2020
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Unita Complessa di Ostetricia e GinecologiaLead sponsor
- Unita Complessa di Ostetricia e GinecologiaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.